Kidney Breakthrough: Health Canada Authorizes First-of-its-Kind Treatment for Lupus Nephritis
Health Canada authorizes Gazyva for lupus nephritis. Discover how this twice-yearly treatment improves kidney response and prevents failure.
New Study Warns of Rapid Weight Regain When Quitting Weight Loss Drugs
New research shows stopping weight loss medication leads to rapid regain, with many returning to their original weight in less than two years.
Does HRT Increase Dementia Risk? New 1M Woman Study
A study of 1M women finds HRT doesn't increase dementia risk. We dive into the findings and why women are still more likely to face Alzheimer's.
Health Canada Authorizes First 8-Week Treatment for Acute Hepatitis C
Health Canada’s approval of MAVIRET for acute HCV allows doctors to treat adults and children immediately, a key step toward the 2030 elimination goal.
Health Canada Authorizes TNKase for Treatment of Adult Stroke
Health Canada officially authorizes TNKase for treating acute ischemic stroke in adults. This pivotal approval introduces a faster, 5-second injection to emergency rooms nationwide.
Generic Ozempic: Canada to See Significant Price Drops
Struggling with high medication costs? Generic Ozempic is coming to Canada in 2026. Learn how prices could drop from $400 to around $100.
Wegovy Authorized as Canada’s First Liver Disease Drug
No more "watchful waiting." Health Canada’s approval of Wegovy gives MASH patients their first tangible medical option to fight liver fibrosis.
Canada Authorizes First-Ever Oral Treatment for Postpartum Depression
Canada approves ZURZUVAE, the first oral PPD pill. This breakthrough 14-day oral therapy aims to elevate the standard of maternal mental health care.
Ozempic, Wegovy and Mounjaro Are Changing Our Food Choices
Appetite-suppressing GLP-1 medications may be changing the way Canadians eat – Smaller appetites and healthier choices are impacting restaurants and the food supply sector in significant ways.
Measles Returns to Canada: The Crisis That Cost Elimination Status
Canada lost its measles-free status after 12 months of spread. Policy loopholes, not just low rates, fueled the crisis in Ontario & Alberta.
Early Alzheimer’s Treatment LEQEMBI Approved by Health Canada
For Canadians facing Alzheimer’s, LEQEMBI offers an option for medication early in the disease process, giving hope, time, and a chance to hold on to precious memories.
Dietary Supplements: Know the Risks of Taking Too Much
More isn’t better. Discover how overdoing popular dietary supplements —from fish oil to B12—can damage your health.